Recommendations for the management and treatment of psoriatic arthritis

作者: Sueli Carneiro , Valderílio Feijó Azevedo , Rubens Bonfiglioli , Roberto Ranza , Célio Roberto Gonçalves

DOI: 10.1016/S2255-5021(13)70030-0

关键词: Placebo-controlled studyMedicineMEDLINEScientific evidenceClinical trialCochrane LibraryObservational studyFamily medicinePsoriatic arthritisJadad scale

摘要: Description of the evidence elaboration method The members Comissao de Espondiloartrites da Sociedade Brasileira Reumatologia (Commission on Spondyloarthritis Brazilian Society Rheumatology, SBR) 2010-2012 took part in Evidence Preparation Course given by Associacao Medica (Brazilian Medical Association, AMB) Sao Paulo first semester 2011. questions were finally concluded at a meeting Commission held 15 October 2011 Florianopolis (SC, Brazil), during 18th Southern Cone Rheumatology Meeting and later approved all coordinators Registry. clinical considered to be relevant structured using P.I.C.O. (patient; intervention or indicator; comparison; outcome). literature search was conducted searching databases MEDLINE, EMBASE, SciElo/Lilacs, Cochrane Library through February, 2012 (Appendix). Critical assessment selected articles performed Jadad score. Next, answers included Recommendations elaborated, references exhibit corresponding grade recommendation strength scientific evidence. updated August, 2012, entered into single file coordinator, sent co-authors two successive rounds for preparation final version. Grades A. Most consistent experimental observational studies. B. Less C. Case reports (uncontrolled studies). D. Opinion that is not substantiated critical evaluation, based consensus, physiological studies animal models. Objective To establish recommendations management (criteria classification assessment) treatment psoriatic arthritis.

参考文章(77)
Annamaria Mazzotta, Maria Esposito, Antonio Costanzo, Sergio Chimenti, Efficacy and Safety of Etanercept in Psoriasis after Switching from Other Treatments American Journal of Clinical Dermatology. ,vol. 10, pp. 319- 324 ,(2009) , 10.2165/11310770-000000000-00000
Euthalia Roussou, Laura Congi, Clinical application of the CASPAR criteria for psoriatic arthritis compared to other existing criteria. Clinical and Experimental Rheumatology. ,vol. 28, pp. 304- 310 ,(2010)
I. Portioli, Carlo Salvarani, G Bisighini, F Rossi, T Cremonesi, P Macchioni, W Mantovani, B Battistel, G Lo Scocco, Prevalence of psoriatic arthritis in Italian psoriatic patients. The Journal of Rheumatology. ,vol. 22, pp. 1499- 1503 ,(1995)
Guenther Haberhauer, Christoph Strehblow, Peter Fasching, Observational study of switching anti-TNF agents in ankylosing spondylitis and psoriatic arthritis versus rheumatoid arthritis Wiener Medizinische Wochenschrift. ,vol. 160, pp. 220- 224 ,(2010) , 10.1007/S10354-010-0795-0
O. Ahlehoff, G. H. Gislason, M. Charlot, C. H. Jørgensen, J. Lindhardsen, J. B. Olesen, S. Z. Abildstrøm, L. Skov, C. Torp-Pedersen, P. R. Hansen, Psoriasis is associated with clinically significant cardiovascular risk: a Danish nationwide cohort study. Journal of Internal Medicine. ,vol. 270, pp. 147- 157 ,(2011) , 10.1111/J.1365-2796.2010.02310.X
David Salonen, Wayne Tsuji, Philip J Mease, Francis X Burch, Joel Rubenstein, John T Sharp, Evan L Siegel, Alan J Kivitz, Peter Ory, Meleana Dunn, Stanley B Cohen, Continued inhibition of radiographic progression in patients with psoriatic arthritis following 2 years of treatment with etanercept. The Journal of Rheumatology. ,vol. 33, pp. 712- 721 ,(2006)
Mohan V Bala, Chenglong Han, Kathy H Fraeman, Monica V Hackett, L Clark Paramore, Don W Robinson, Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis The Journal of Rheumatology. ,vol. 33, pp. 2167- 2172 ,(2006)
Sensi F, Zoppini A, Spadaro A, Taccari E, Sili-Scavalli A, Riccieri, Comparison of cyclosporin A and methotrexate in the treatment of psoriatic arthritis: a one-year prospective study. Clinical and Experimental Rheumatology. ,vol. 13, pp. 589- 593 ,(1995)
Mark C Genovese, Philip J Mease, Glen TD Thomson, Alan J Kivitz, Renee J Perdok, Mark A Weinberg, John Medich, Eric H Sasso, M02-570 Study Group, Safety and efficacy of adalimumab in treatment of patients with psoriatic arthritis who had failed disease modifying antirheumatic drug therapy. The Journal of Rheumatology. ,vol. 34, pp. 1040- 1050 ,(2007)
JC Prinz, O FitzGerald, RL Boggs, J Foehl, D Robertson, R Pedersen, CT Molta, B Freundlich, Combination of skin, joint and quality of life outcomes with etanercept in psoriasis and psoriatic arthritis in the PRESTA trial. Journal of The European Academy of Dermatology and Venereology. ,vol. 25, pp. 559- 564 ,(2011) , 10.1111/J.1468-3083.2010.03838.X